airmid healthgroup Helps Spring Air Develop World’s First asthma & allergy friendly Certified Mattress

More than 60 million American adults and children live with asthma or allergies, which are chronic respiratory diseases characterized by sneezing, wheezing, coughing and difficulty breathing. Bedrooms, beds – and mattresses in particular – can be major sources of asthma and allergy triggers, since they often harbour dust mites, pet dander, irritating chemicals and gases, and more. So it’s no surprise that patients frequently report night-time symptoms, difficulty sleeping, and morning congestion as some of their most common frustrations.

Now, the world’s first Certified asthma & allergy friendly™ mattress has been designed thanks to a successful research & development partnership between Spring Air and airmid healthgroup. airmid provided advanced research & design advice during the prototype and commercialization stages for Spring Air’s new-generation of Breathe™ mattresses.

airmid’s unique research and scientific experience provided Spring Air with the capabilities and knowledge to manufacture a set of mattresses that could receive asthma & allergy friendly™ certification by the Asthma and Allergy Foundation of America (AAFA), the first certification of its kind for a mattress.

Spring Air, a leading US brand of mattresses, wished to continue their company tradition of innovative product positioning. Partnering with airmid healthgroup, an ISO 17025:2005 accredited testing laboratory for house dust mite allergen (Der p 1), they undertook a research and development project to construct a better product that would achieve certification.

The mattress development project focused on making the sleep environment more suitable for people with asthma and allergies. airmid used controlled environmental chambers and state of the art analytical technology and applied a three-stage testing process:

  • Stage 1 – Barrier Function of Encasing Materials
  • Stage 2 – Component Emission Testing
  • Stage 3 – Real-Time Allergen Testing on Constructed Product

"Since 1926, Spring Air has marketed innovative mattresses and sleep sets to the US consumer’” said Rick Robinson, President at Spring Air. “Today, our investment in ground-breaking research with our partner airmid healthgroup provides us a new and superior ability to develop even better products to make the bedroom healthier.”

“We’re excited to partner with a progressive company like Spring Air, and play a role in their efforts to innovate products with technological and marketing advantages,” said Dr. Bruce Mitchell, CEO at airmid healthgroup. “They join a growing list of successful companies that have leveraged our chamber and integrated analytical facilities and resources to provide their customers with the highest quality products.”

The certified matrasses are already available through the Costco web site.

Continue Reading


Carpet and IAQ study from US Immunology Conference has Significant Media Pick Up

There was a huge amount of interest during the recent presentation by Dr Angela Southey of a research project carried out in the airmid healthgroup climate controlled test chambers. Dr Southey was one of the lead researchers on the project. The data was presented during the American Academy of Asthma Allergy and Immunology (AAAAI) Annual Meeting 2012, March 2-6, in Orlando Florida.

"We were delighted with the interest in the study from health care professionals and the media" said Dr Southey. The message picked up by the media was ‘Carpets may not be the culprit’ which is a break with the current thinking in some sectors of health care professionals. 

"We are very pleased this has been picked up by the media" said Dr Bruce Mitchell, airmid CEO, "our mission is to assist our clients’ research capabilities, generate high class data and most importantly convert it into value. The current study and the issue of biological and non-biological ultrafine particles is a great example of this".

Continue Reading


airmid healthgroup announces increased sensitivity for Fel d 1 ELISA (SP301)

Indoor Biotechnologies, manufacturers of a comprehensive range of quantitative ELISA kits for allergens, have enhanced the sensitivity of the Fel d 1 ELISA. The improvement carried out by Indoor Biotechnologies is based on a modified biotinylation technique used to create the biotinylation detection antibody (BI-3E4).

airmid healthgroup will therefore report the new detection limit of 0.13ng/ml compared to a previous detection limit of 0.5ng/ml. Validation studies with the Internal Quality Control samples have been carried out according to the ISO 17025:2005 standard.

The new detection limits will be as follows:

Der p 1 1.00ng/ml or 0.025μg/g*

Fel d 1 0.13ng/ml or 0.003μg/g*

Der f 1 0.5ng/ml or 0.013μg/g*

Mite Group 2 0.25ng/ml or 0.006μg/g*

Phl p 5 0.4ng/ml or 0.01μg/g*

Amp Der p 1 20pg/ml

Amp Fel d 1 2.5pg/ml

*Limits are based on a standard volume PBST (2.5ml) and a standard weight of dust (0.1g).

airmid healthgroup works continually to enhance and develop our testing methods to ensure the most efficient service possible.

For further details contact: Máire Fox MSc, Laboratory Manger and Quality Manager.


airmid healthgroup Demonstrates Baby Mattress As Effective Allergen Barrier

DUBLIN, Ireland, March 6th 2012

Bluebear Nursery today released the findings from an allergen barrier efficacy study, undertaken on one of their leading baby mattress brands, 'Aerosleep Baby Protect'. The study was conducted by Dublin-based airmid healthgroup, the world's first ISO accredited testing laboratory for house dust mite and cat allergen analysis. The results confirm AeroSleep's claim that the protective fabric provided a barrier that is at least 99.77% effective against House Dust Mite and Cat allergen.

aerosleepUnder the terms of the study, airmid provided laboratory testing services on the protective fabric on the 'AeroSleep Baby Protect ', a mattress protector manufactured by AeroSleep, and distributed by Bluebear Nursery in Ireland. Two allergen barrier tests were conducted that replicated Cat Allergen and House Dust Mite Allergen being pulled through the fabric by airflow and also mechanical agitation. airmid is already a recognized testing partner to the US asthma & allergy friendlyTM Certification Program.

bluebear nursery"Bluebear Nursery has been researching and distributing high-quality baby nursery products in Ireland since 2003", said Declan Power, Director at Bluebear Nursery. "Our investment in independent research with our partner, airmid healthgroup, provides our customers with the reassurance that science underpins our product claims relating to Allergen Barrier Efficacy".

"The results demonstrate that the protective fabric on Aerosleep Baby Protect Mattresses can be considered an effective allergen barrier," said Fraser Hodgson, chief operations officer at airmid. "They join other bedding manufacturers that have leveraged our testing resources to provide customers with independent science to support product health-related claims. Third-party testing is an important component of their customer value proposition and we're glad to play a role in their efforts".

Continue Reading


airmid healthgroup Signs R&D Partnership With Bedding Manufacturer Spring Air

DUBLIN, IRELAND and WASHINGTON, DC--(March 16, 2011)

airmid healthgroup, a Dublin-based research facility for a wide range of consumer products including new sleep products, today announced a research and development partnership with Spring Air International, a leading US manufacturer of bedding products. Under the terms of the deal, airmid will provide advanced research & laboratory testing services for Spring Air's new-generation bedding products. airmid is already a recognized testing partner to the US asthma & allergy friendlyTM Certification Program. The agreement further extends the company's US market presence.

The deal was announced today during a business luncheon in Washington, D.C. to mark Ireland's strong commercial links with the US. Featuring Ireland's new Prime Minister, Enda Kenny, the event was organized by Enterprise Ireland, the government agency responsible for the development and growth of Irish enterprises in world markets.

"Since 1926, Spring Air has provided innovative mattresses and sleep sets to the US consumer," said Rick Robinson, President at Spring Air. "Our investment in ground-breaking research with our partner airmid healthgroup, will provide new and superior, third-party-validated, healthy sleep products."

"We're excited to partner with a progressive company like Spring Air," said Dr. Bruce Mitchell, chief executive officer at airmid. "They join other global bedding leaders that have leveraged our testing resources to provide customers with the highest quality products. These companies are proactive leaders in the global drive to reduce ill health due to indoor air pollutants - a major cause of the asthma and allergies that affect more than 70 million Americans. Third-party testing is an important component of their customer value proposition. We're glad to play a role in their efforts by helping them innovate products with technological and marketing advantages."

Continue Reading


airmid Research Data Highlighted at Innovation Convention by European Commissioner

December 14th, 2011

airmid healthgroup’s data was singled out for praise at the recent inaugural Innovation Convention 2011 in Brussels. The Convention was led by the President of the European Commission, José Manuel Barroso.

airmid-biomedical-research-data-highlighted-at-innovation-convention-by-European-Commissioner_sThe airmid data was a key aspect to an Irish research project on ceramic tiles that can kill pathogens. The project, one of 50 selected from over 450 EU Research Projects to participate in Europe’s premier innovation event, was driven by researchers at the Centre for Research in Engineering Surface Technology (CREST), part of the Dublin Institute of Technology and Radical Coatings, a company that develops advanced coating technologies, including photocatalytic coatings for hygiene control.

The tiles were on display at EU Innovation Convention in Brussels and the EU Commissioner for Research, Innovation and Science Máire Geoghegan-Quinn visited the stand at the convention to learn about this innovative project.

Tests carried out at airmid healthgroup in Dublin validated that the technology is 99.99 % efficient at killing the hospital ‘superbug’ MRSA, E. coli and Trichophyton rubrum (the fungus that causes athlete’s foot).

The photocatalytic antibacterial surface coating technology developed by a research team at DIT was converted into a commercial product (using funding from Enterprise Ireland) by Robert Hickson, MD of VitrA Ireland, who has applied the light activated surface technology for use on ceramics.

According to Dr Martin Lyes, Enterprise Ireland, “this shows how EU funding for networking in science brought together leading companies, research centres and universities, enhancing Europe’s innovation and creating jobs”.

There was a strong Irish based innovation theme running through the whole convention. Eric Schmidt, executive chairman of Google, was asked by Máire Geoghegan-Quinn during the question and answer session why Google chose Ireland to be its European headquarters. Schmidt confirmed it was due to the innovation culture in Ireland and particularly access to strong local graduate talent. This endorsement of Ireland and its young entrepreneurs was also being transmitted live by Webinar around the world. It is heartening to see Irish entrepreneurs and Ireland doing so well on a key European platform.


An Taoiseach Celebrates World's First for Dublin Laboratory

DUBLIN, Ireland, November 10th 2011

An Taoiseach Enda Kenny today congratulated Dublin based research facility, airmid healthgroup on their world first, of becoming ISO accredited in a biomedical field of indoor air pollution and health. airmid are ISO17025 accredited for the analysis of Cat & House Dust Mite allergen levels.

enda-kenny-and-bruce-mitche“The companies we work with are proactive leaders in the global drive to reduce ill health due to indoor air pollutants —a major cause of the asthma and allergies that affect a growing percentage of the population” says airmid CEO Dr Bruce Mitchell. “Third-party testing is an important component of customer value proposition, and we’re glad to play a role in efforts by manufacturers to innovate health related products.  Becoming the first ISO 17025 accredited laboratory in the world for Cat & House Dust Mite Allergen testing is something we are proud of, and gives manufacturers and consumers the peace of mind they are investing in the best”.

airmid healthgroup reflects the huge achievements of Ireland in the area of life sciences, and in biomedical research in particular.  Ireland is now in the top 20 in the world for the quality and relevance of our scientific research and due to the efforts of companies like airmid, we are now the number one location in Europe for Life sciences projects. And this strength is reflected in terms of multinational investment, exports and jobs” said An Taoiseach, Enda Kenny.



Continue Reading


Rexair Receives asthma & allergy friendly™ Certification Mark in the USA

Dublin, Ireland, August 2011

airmid healthgroup ltd, a world leading biomedical research company, are again pleased to learn that one of its research and innovation clients, Rexair, has recently been awarded the valued asthma & allergy friendlyTM Certification Mark in the United States of America by Allergy Standards Ltd. Rexair started the comprehensive development project with airmid healthgroup ltd in July 2010. The announcement was made at a recent Rexair AGM where the President and CEO Paul Vidovich received an award relating to the research and Certification (pictured below).

"I am extremely delighted that following the extensive research Rexair conducted with airmid healthgroup ltd they have been awarded the asthma & allergy friendlyTM Certification Mark in the United States of America", said Dr Bruce Mitchell, CEO of airmid healthgroup ltd. "Rexair are thought leaders in the area of air quality and we look forward to working with them in the future in other areas related to air quality".

The certified product will soon be available through the Rexair direct sales force.

rexair_2_small rexair_1_small


airmid healthgroup ltd appoints Microbiologist

Dublin, 8th August 2011

airmid healthgroup ltd are delighted to announce the appointment of another PhD graduate, to their already multifaceted science team. At an exciting time of development John Fallon PhD, has joined airmid healthgroup ltd as Senior Scientific Officer in the specialist area of Microbiology. This appointment will enhance airmid's capability to produce market-led, health-related knowledge for client's products and services.

John graduated from the National University of Ireland Maynooth with a BSc in Biological Sciences. Following completion of his undergraduate studies John remained at NUIM to complete a PhD in the medical mycology unit examining the disease causing potential of environmental isolates of Aspergillus fumigatus in vertebrate and invertebrate immune systems.

Continue Reading


airmid healthgroup ltd Continues Growth with Appointment of New Senior Scientific Officer

Dublin, 20th July 2011

airmid healthgroup ltd, a world leading bio-medical research facility, have demonstrated their continued growth with the appointment of Vivienne Mahon PhD as the Senior Scientific Officer/Laboratory Research. This appointment will enhance airmid's ability to deliver market changing, health-related knowledge about products and services.

A recipient of a prestigious academic gold medal from Trinity College Dublin, Vivienne graduated with a B.A. (Mod) degree in microbiology and then remained at Trinity to complete a PhD in molecular microbiology that focused on the regulation of gene expression in enterotoxigenic E. coli. As a post-doctoral scientist Vivienne spent two years in the National Institute for Bioprocessing, Research and Training (NIBRT) working on mammalian cell culture media development and optimisation.

Vivienne joins a multidisciplinary team of Clinicians, Industrial Hygienists, Occupational Health Advisers, and specialist laboratory scientists in mycology, virology, bacteriology, allergy and immunology.

Continue Reading


Dr McKeon Invited to Speak at Marie Curie Lecture Series

Dublin, 29th June 2011 

Dr John McKeon, co-founder of airmid healthgroup ltd, was recently invited to be a guest speaker and sit on the judging panel at a post-doctoral workshop on Entrepreneurship as part of the Marie Curie International Training Network.

"I was delighted to speak at this prestigious Marie Curie workshop and be asked to be on the judging panel," said Dr McKeon. "We have strong links with the college both with the graduate school of business and in life sciences research. This event, along with our attendance at the opening by the Irish Prime Minister of the Trinity Biomedical Institute, is a great example of how our location in the Trinity Enterprise Campus allows us to position airmid healthgroup ltd at the forefront of life sciences research and innovation at a European and Global level".

The lecture series was organised by Professor O'Neill, from the Trinity School of Business, and Bridget Noone, Enterprise Executive, Trinity Research and Innovation, and held in the lecture theatres in the Trinity Enterprise Campus.

This Marie Curie action initiative, LeCHE, is described as ideal training for future researchers in Europe, drawing together leading research teams in the world, state-of-the-art methods and a clearly focused, important and emotive question with widespread repercussions and integrates them using sophisticated tools and training devices.

The large, 15 researcher, 24 participant, European training network explores the origin and impact of dairying in Europe. The participating researchers will draw on the latest genetic studies of modern humans and domestic animals to identify markers of specific traits.

The Entrepreneurship master class covered key themes such as idea generation, value proposition, intellectual property, market analysis and business models. It colminated in a pitch presentation to a panel including venture capitalists, entrepreneurs and business consultants.

The winners were Zooms, for the innovative commercialisation model for collagen sampling, which already has had its first customer in the UK Police where their technique proved superior and more commercially relevant than traditional identification methods.

Continue Reading